Atika Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-92,000
| Closed | -$1.89M | – | 96 |
|
|
2024
Q3 | $1.89M | Buy |
+92,000
| New | +$1.89M | 0.19% | 70 |
|
|
2022
Q4 | – | Sell |
-100,000
| Closed | -$5.6M | – | 85 |
|
|
2022
Q3 | $5.6M | Buy |
100,000
+76,500
| +326% | +$4.28M | 0.47% | 52 |
|
|
2022
Q2 | $1.22M | Sell |
23,500
-6,500
| -22% | -$336K | 0.14% | 53 |
|
|
2022
Q1 | $2.18M | Buy |
+30,000
| New | +$2.18M | 0.18% | 55 |
|
|
2021
Q4 | – | Sell |
-64,000
| Closed | -$8.59M | – | 105 |
|
|
2021
Q3 | $8.59M | Buy |
64,000
+1,000
| +2% | +$134K | 0.51% | 64 |
|
|
2021
Q2 | $10.2M | Buy |
+63,000
| New | +$10.2M | 0.8% | 49 |
|